CVI Investments, Inc. 13D/13G Filings for INmune Bio, Inc. (INMB)

CVI Investments, Inc. 13D and 13G filings for INmune Bio, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-07-02
10:09 am
Purchase
2025-06-2713GINmune Bio, Inc.
INMB
CVI Investments, Inc.1,500,000
5.500%
1,500,000increase
(New Position)
Filing